Motohiro A, Hirota N, Komatsu H, Yanai N
Department of Surgery, National Minamifukuoka Chest Hospital, Fukuoka, Japan.
Lung Cancer. 1994 Jul;11(1-2):43-50. doi: 10.1016/0169-5002(94)90281-x.
We conducted a trial to clarify what Japanese clinical doctors think about the present status of therapy for non-small cell lung cancer, as well as to clarify which problems are still unresolved. One-hundred five Japanese doctors who treat lung cancer patients were asked how they would choose to be treated, if they suffered from non-small cell lung cancer. Six scenarios were presented and the doctors had to choose one treatment method for each of the six scenarios. Adjuvant chemotherapy or radiotherapy after complete resection, increase with progression of the pathological stage. Ninety-three per cent of Japanese doctors wanted surgery, even if mediastinal lymph node metastases were present. In the scenario of only one distant metastasis to the brain, 44% of doctors wanted surgery while 39% wanted chemotherapy and/or radiotherapy. In the scenario of multiple bone metastases, 33% wanted chemotherapy, 77% did not. It was concluded therefore that Japanese doctors choose surgery as the number one treatment modality when all lesions are considered resectable.
我们进行了一项试验，以阐明日本临床医生对非小细胞肺癌治疗现状的看法，并明确哪些问题仍未得到解决。我们询问了105名治疗肺癌患者的日本医生，如果他们患有非小细胞肺癌，他们会选择如何接受治疗。我们给出了六种情况，医生们必须针对这六种情况中的每一种选择一种治疗方法。完全切除术后的辅助化疗或放疗，会随着病理分期的进展而增加。93%的日本医生希望进行手术，即使存在纵隔淋巴结转移。在仅有一处脑远处转移的情况下，44%的医生希望进行手术，而39%的医生希望进行化疗和/或放疗。在有多发性骨转移的情况下，33%的医生希望进行化疗，77%的医生不希望。因此得出结论，当所有病灶都被认为可切除时，日本医生将手术作为首选的治疗方式。
